Decision

Advertising investigations: June 2015

Decisions made by MHRA following an investigation into complaints about advertising for licensed medicines.

• From: Medicines and Healthcare products Regulatory Agency
• Published: 20 July 2015

Documents

June 2015: clinics advertising botulinum toxin products

HTML

8 June 2015: advertising of Prednisolone Dompé

HTML

9 June 2015: advertising of Nicardipine

HTML

26 June 2015: promotion of an unlicensed medicine

HTML

Details

Contact advertising@mhra.gsi.gov.uk if you have concerns with the advertising of medicines or write to:

Advertising Standards Unit,
151 Buckingham Palace Road,
Victoria,
London SW1W 9SZ.

Alternatively, contact the pharmaceutical self-regulatory bodies, the Proprietary Association of Great Britain (PAGB) for advertising for over the counter medicines, or the Prescription Medicines Code of Practice Authority (PMCPA) for advertisements to health professionals for prescription medicines.

Published 20 July 2015